Peroxidase-mimicking evodiamine/indocyanine green nanoliposomes for multimodal imaging-guided theranostics for oral squamous cell carcinoma

Peroxidase-mimicking evodiamine/indocyanine green nanoliposomes for multimodal imaging-guided theranostics for oral squamous cell carcinoma

Here, evodiamine (EVO) and the photosensitizer indocyanine green (ICG) were integrated into a liposomal nanoplatform for noninvasive diagnostic imaging and combinatorial therapy against oral squamous cell carcinoma (OSCC). EVO, as an active component extracted from traditional Chinese medicine, not...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Zheng Wei, Huihui Zou, Gongyuan Liu, Chuanhui Song, Chuanchao Tang, Sheng Chen, Guorong Zhang, Jianchuan Ran, Yufeng Wang, Xiteng Yin, Yu Cai, Wei Han
Natura:	Articolo
Lingua:	English
Pubblicazione:	KeAi Communications Co., Ltd. 2021-07-01
Serie:	Bioactive Materials
Soggetti:	Oral squamous cell carcinoma Evodiamine Peroxidase-mimicking Trimodal antitumor therapy
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2452199X2030342X

Documenti analoghi

Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity
di: Yahui Huang, et al.
Pubblicazione: (2020-07-01)

Design, Synthesis and Evaluation of N13-Substituted Evodiamine Derivatives against Human Cancer Cell Lines
di: Senchuan Song, et al.
Pubblicazione: (2013-12-01)

Antitumor activity of 2 new evodiamine derivatives against small-cell lung cancer cells in vitro
di: JIANG Xuejun, et al.
Pubblicazione: (2019-05-01)

Inhibitory Effect of Evodiamine on Psoriasis Lesions and Itching in Mice
di: Liang J, et al.
Pubblicazione: (2024-06-01)

Pharmacological Actions of Multi-Target-Directed Evodiamine
di: Zhanli Wang, et al.
Pubblicazione: (2013-01-01)

Maintaining calcium homeostasis as a strategy to alleviate nephrotoxicity caused by evodiamine
di: Chun-qi Yang, et al.
Pubblicazione: (2024-08-01)

Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity
di: Jau-Lang Hwang, et al.
Pubblicazione: (2009-03-01)

Development of a novel N14-substituted antitumor evodiamine derivative with inhibiting heat shock protein 70 in non-small cell lung cancer
di: Hye-Young Min, et al.
Pubblicazione: (2024-10-01)

Evodiamine: A Novel Anti-Cancer Alkaloid from Evodia rutaecarpa
di: Changping Hu, et al.
Pubblicazione: (2009-05-01)

Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa
di: Lin L, et al.
Pubblicazione: (2024-09-01)

Dietary supplementation with evodiamine prevents obesity and improves insulin resistance in ageing mice
di: Hitoshi Yamashita, et al.
Pubblicazione: (2015-12-01)

Therapeutic effect of evodiamine on atopic dermatitis in rat models
di: JIANG Su, LYU Xinxiang, CUI Yanhong, LYU Liting, LI Dongxia
Pubblicazione: (2024-09-01)

Evodiamine Exerts Anticancer Effects Against 143B and MG63 Cells Through the Wnt/β-Catenin Signaling Pathway
di: Yang S, et al.
Pubblicazione: (2020-04-01)

Molecular Dynamics Simulation of the Complex of PDE5 and Evodiamine
di: Ayame Kobayashi, et al.
Pubblicazione: (2023-02-01)

Evodiamine Attenuates Experimental Colitis Injury Via Activating Autophagy and Inhibiting NLRP3 Inflammasome Assembly
di: Wenwen Ding, et al.
Pubblicazione: (2020-11-01)

The Protective Effect of Evodiamine in Osteoarthritis: An In Vitro and In Vivo Study in Mice Model
di: Shuyuan Xian, et al.
Pubblicazione: (2022-06-01)

Hot-Electron-Activated Peroxidase-Mimicking Activity of Ultrathin Pd Nanozymes
di: Yonghua Tang, et al.
Pubblicazione: (2020-08-01)

Evodiamine derivatives improve cognitive abilities in APPswe/PS1ΔE9 transgenic mouse models of Alzheimer's disease
di: Shuo Pang, et al.
Pubblicazione: (2020-06-01)

Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells
di: Sun Tae Hwang, et al.
Pubblicazione: (2020-03-01)

Antitumor Effects of Evodiamine in Mice Model Experiments: A Systematic Review and Meta-Analysis
di: Cong Yin, et al.
Pubblicazione: (2021-11-01)

Traditional Chinese medicine for anti-Alzheimer’s disease: berberine and evodiamine from Evodia rutaecarpa
di: Zhiling Fang, et al.
Pubblicazione: (2020-08-01)

Peroxidase-mimicking TA-VOx nanobranches for enhanced photothermal/chemodynamic therapy of glioma by inhibiting the expression of HSP60
di: Qinglong Guo, et al.
Pubblicazione: (2022-12-01)

The effects of evodiamine on serum total cholesterol and triglyceride levels are associated with the activation of the AMPK signaling pathway in rats with hyperlipemia
di: Yu Hui, et al.
Pubblicazione: (2016-01-01)

Evodiamine Augments NLRP3 Inflammasome Activation and Anti-bacterial Responses Through Inducing α-Tubulin Acetylation
di: Chen-Guang Li, et al.
Pubblicazione: (2019-03-01)

Design, synthesis, and biological evaluation of benzenesulfonyl chloride-substituted evodiamine derivatives as potential PGAM1 inhibitors
di: Binbin Wei, et al.
Pubblicazione: (2023-11-01)

Induction of Apoptosis and Effect on the FAK/AKT/mTOR Signal Pathway by Evodiamine in Gastric Cancer Cells
di: Ji Yeong Yang, et al.
Pubblicazione: (2022-09-01)

Characterization of the in Vitro Metabolic Profile of Evodiamine in Human Liver Microsomes and Hepatocytes by UHPLC-Q Exactive Mass Spectrometer
di: Zhaowei Zhang, et al.
Pubblicazione: (2018-02-01)

Sensitive and Label-Free Colorimetric Detection of Glyphosate Based on the Suppression Peroxidase-Mimicking Activity of Cu(II) Ions
di: Qing Li, et al.
Pubblicazione: (2023-06-01)

Daily chemical evodiamine from Chinese prickly ash attenuates osteoclast differentiation through RANKL induced NFAT pathways
di: Lei Jiang, et al.
Pubblicazione: (2017-10-01)

Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway
di: Che-Yuan Hu, et al.
Pubblicazione: (2017-07-01)

Evodiamine, a Novel NOTCH3 Methylation Stimulator, Significantly Suppresses Lung Carcinogenesis in Vitro and in Vivo
di: Tao Su, et al.
Pubblicazione: (2018-05-01)

Design, synthesis, and biological evaluation of evodiamine-indolequinone hybrids as novel NQO1 agonists against non-small cell lung cancer
di: BinBin Wei, et al.
Pubblicazione: (2025-01-01)

Metabolic characteristics of evodiamine were associated with its hepatotoxicity via PPAR/PI3K/AKT/NF-кB/tight junction pathway-mediated apoptosis in zebrafish
di: Qiqi Fan, et al.
Pubblicazione: (2024-07-01)

Consistent RNA expression and RNA modification patterns in cardiotoxicity induced by Matrine and Evodiamine
di: Guanhua Fang, et al.
Pubblicazione: (2025-01-01)

Experimental and computational study on anti-gastric cancer activity and mechanism of evodiamine derivatives
di: Jingli Liu, et al.
Pubblicazione: (2024-05-01)

Evodiamine Alleviates 2,4-Dinitro-1-Chloro-Benzene-Induced Atopic Dermatitis-like Symptoms in BALB/c Mice
di: So-Young Han, et al.
Pubblicazione: (2024-04-01)

Evodiamine suppresses endometriosis development induced by early EBV exposure through inhibition of ERβ
di: Junling Wang, et al.
Pubblicazione: (2024-08-01)

Evodiamine inhibits proliferation and induces apoptosis of nasopharyngeal carcinoma cells via the SRC/ERBB2-mediated MAPK/ERK signaling pathway
di: Jie Liu, et al.
Pubblicazione: (2024-09-01)

Effect of Evodiamine on Rat Colonic Hypermotility Induced by Water Avoidance Stress and the Underlying Mechanism
di: Ren H, et al.
Pubblicazione: (2021-02-01)

The nanocomposite system comprising folic acid-modified graphene quantum dots loaded with evodiamine in the treatment of oral squamous cell carcinoma
di: Yu Ma, et al.
Pubblicazione: (2022-08-01)